Cited by 110Helicobacter pylori-related gastroenterology studiesGut microbiota and healthOral microbiology and periodontitis research

Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients

Open access
Paroni Sterbini, Francesco, Palladini, Alessandra, Masucci, Luca, Cannistraci, Carlo Vittorio, Pastorino, Roberta, Ianiro, Gianluca, Bugli, Francesca, Martini, Cecilia +5 more·2016·Applied and Environmental Microbiology

Abstract

Besides being part of anti- Helicobacter pylori treatment regimens, proton pump inhibitors (PPIs) are increasingly being used to treat dyspepsia. However, little is known about the effects of PPIs on the human gastric microbiota, especially those related to H. pylori infection. The goal of this study was to characterize the stomach microbial communities in patients with dyspepsia and to investigate their relationships with PPI use and H. pylori status. Using 16S rRNA gene pyrosequencing, we analyzed the mucosa-associated microbial populations of 24 patients, of whom 12 were treated with the PPI omeprazole and 9 (5 treated and 4 untreated) were positive for H. pylori infection. The Proteobacteria , Firmicutes , Bacteroidetes , Fusobacteria , and Actinobacteria phyla accounted for 98% of all of the sequences, with Helicobacter , Streptococcus , and Prevotella ranking among the 10 most abundant genera. H. pylori infection or PPI treatment did not significantly influence gastric microbial species composition in dyspeptic patients. Principal-coordinate analysis of weighted UniFrac distances in these communities revealed clear but significant separation according to H. pylori status only. However, in PPI-treated patients, Firmicutes , particularly Streptococcaceae , were significantly increased in relative abundance compared to those in untreated patients. Consistently, Streptococcus was also found to significantly increase in relation to PPI treatment, and this increase seemed to occur independently of H. pylori infection. Our results suggest that Streptococcus may be a key indicator of PPI-induced gastric microbial composition changes in dyspeptic patients. Whether the gastric microbiota alteration contributes to dyspepsia needs further investigation. IMPORTANCE Although PPIs have become a popular treatment choice, a growing number of dyspeptic patients may be treated unnecessarily. We found that patients treated with omeprazole showed gastric microbial communities that were different from those of untreated patients. These differences regarded the abundances of specific taxa. By understanding the relationships between PPIs and members of the gastric microbiota, it will be possible to envisage new strategies for better managing patients with dyspepsia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aem.01437-16

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The primary abundance of Streptococcaceae was also demonstrated in dyspeptic patients during PPI treatment, suggesting that this ecological switch in favor of Streptococcaceae could be an independent indicator of gastric dysbiosis due to these drugs.

    “The primary abundance of Streptococcaceae was also demonstrated in dyspeptic patients during PPI treatment, suggesting that this ecological switch in favor of Streptococcaceae could be an independent indicator of gastric dysbiosis due to these drugs[59].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Paroni Sterbini, F., Palladini, A., Masucci, L., Cannistraci, C. V., Pastorino, R., Ianiro, G., Bugli, F., Martini, C., Ricciardi, W., Gasbarrini, A., Sanguinetti, M., Cammarota, G., & Posteraro, B.
Affiliations
  • Institute of Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy
  • Università Cattolica del Sacro Cuore (IT)
  • Biotechnologisches Zentrum (DE)
Venue
Applied and Environmental Microbiology
Published
2016-11-15
Volume
82
Issue
22
Pages
6633-6644
ISSN
  • 0099-2240 (ISSN-L)
  • 1098-5336
OpenAlex
W2517918142
Cited by
108
References
60
Citations by year
2026: 7 · 2025: 10 · 2024: 10 · 2023: 11 · 2022: 11 · 2021: 18 · 2020: 12 · 2019: 14 · 2018: 6 · 2017: 8
FWCI
10.34
Type
journal article
Language
en
Open access
Locations
  • Applied and Environmental Microbiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Università Cattolica del Sacro Cuore (Linea D1, Linea D3.2-2013)
  • Technische Universität Dresden
Topics
  • Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
proton pump inhibitors, omeprazole, dyspepsia, gastric microbiota, Helicobacter pylori infection, Streptococcus, Streptococcaceae, Firmicutes, Helicobacter, dyspepsia treatment
MeSH terms
Firmicutes, Bacillota, Gastrointestinal Microbiome, Adult, Aged, Anti-Bacterial Agents, Bacteria, Dyspepsia, Female, Gastric Mucosa, Humans, Middle Aged, Omeprazole, RNA, Ribosomal, 16S, Streptococcus, Helicobacter pylori, Helicobacter Infections, Genes, rRNA, Proteobacteria, Bacteroidetes, Proton Pump Inhibitors, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review